KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EBITDA: 2019-2024

Historic EBITDA for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $125.8 million.

  • Hims & Hers Health's EBITDA fell 79.11% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.5 million, marking a year-over-year increase of 32.34%. This contributed to the annual value of $125.8 million for FY2024, which is 637.93% up from last year.
  • Hims & Hers Health's EBITDA amounted to $125.8 million in FY2024, which was up 637.93% from -$23.4 million recorded in FY2023.
  • In the past 5 years, Hims & Hers Health's EBITDA registered a high of $125.8 million during FY2024, and its lowest value of -$107.8 million during FY2021.
  • In the last 3 years, Hims & Hers Health's EBITDA had a median value of -$23.4 million in 2023 and averaged $12.2 million.
  • In the last 5 years, Hims & Hers Health's EBITDA tumbled by 494.61% in 2021 and then skyrocketed by 637.93% in 2024.
  • Yearly analysis of 5 years shows Hims & Hers Health's EBITDA stood at -$18.1 million in 2020, then slumped by 494.61% to -$107.8 million in 2021, then soared by 38.94% to -$65.8 million in 2022, then skyrocketed by 64.46% to -$23.4 million in 2023, then surged by 637.93% to $125.8 million in 2024.